CytomX Masked ADC Shows Colorectal Promise
4 articles curated from biotech news
CytomX surges on positive data for ‘masked’ ADC in colorectal cancer
BioPharma DiveMar 16, 2026Cytomx soars as early colorectal cancer data beat expectations
BioWorld (Clarivate)Mar 16, 2026CytomX reports ADC data in late-line colorectal cancer; FDA OKs Cosentyx label expansion
Endpoints NewsMar 16, 2026CytomX’s Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer
Globle News Wire - Clinical StudyMar 16, 2026
Want daily biotech news like this? Sign up free